SANTA FE, NM--The National Center for Genome Resources, a nonprofit provider of bioinformatics tools and public databases here, appointed Jeffrey Casdin, CEO of Casdin Capital Partners, to its board of directors. Casdin has been engaged in investment analysis of the biotechnology industry since 1985 as a publisher, research analyst, and portfolio manager. He has managed Casdin Capital Partners in New York since early 1997, and previously served as a first vice-president responsible for biotechnology investment research at Merrill Lynch, and as senior vice-president and managing director of Oppenheimer overseeing biotechnology research.
Casdin Appointed to NCGR Board of Directors
Dec 18, 1998